Akcea Therapeutics, Inc. Operating Income
Akcea Therapeutics, Inc. reported Operating Income of -$51.09 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2020-08-05
- Akcea Therapeutics, Inc. operating income (loss) for the quarter ending 2020-06-30 was -$51.09M.
- Akcea Therapeutics, Inc. operating income (loss) for the quarter ending 2020-03-31 was -$45.26M, a 272.70% decline year-over-year.
- Akcea Therapeutics, Inc. operating income (loss) for the quarter ending 2019-12-31 was $83.16M.
- Akcea Therapeutics, Inc. operating income (loss) for the quarter ending 2019-09-30 was -$32.59M.
- Akcea Therapeutics, Inc. operating income (loss) for fiscal 2019 was $38.07M.
- Akcea Therapeutics, Inc. operating income (loss) for fiscal 2018 was -$230.82M.
- Akcea Therapeutics, Inc. operating income (loss) for fiscal 2017 was -$120.47M.
- Akcea Therapeutics, Inc. operating income (loss) for fiscal 2016 was -$83.51M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | -$51.09M 10-Q · filed 2020-08-05 | -$96.35M 10-Q · filed 2020-08-05 | -$13.19M derived: sum of 3 quarters · filed 2020-08-05 | -$45.78M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2020-03-31 | -$45.26M 10-Q · filed 2020-05-06 | $37.90M derived: sum of 2 quarters · filed 2020-05-06 | $5.31M derived: sum of 3 quarters · filed 2020-05-06 | -$33.39M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-12-31 | $83.16M 10-K · filed 2020-03-02 | $50.57M derived: sum of 2 quarters · filed 2020-03-02 | $11.87M derived: sum of 3 quarters · filed 2020-08-05 | $38.07M 10-K · filed 2020-03-02 | ||||
| 2019-09-30 | -$32.59M 10-K · filed 2020-03-02 | -$71.30M derived: sum of 2 quarters · filed 2020-08-05 | -$45.09M 10-Q · filed 2019-11-06 | -$117.15M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-06-30 | -$38.71M 10-Q · filed 2020-08-05 | -$12.50M 10-Q · filed 2020-08-05 | -$84.56M derived: sum of 3 quarters · filed 2020-08-05 | -$149.56M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | $26.21M 10-Q · filed 2020-05-06 | -$45.85M derived: sum of 2 quarters · filed 2020-05-06 | -$110.86M derived: sum of 3 quarters · filed 2020-05-06 | -$174.28M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | -$72.06M 10-K · filed 2020-03-02 | -$137.07M derived: sum of 2 quarters · filed 2020-03-02 | -$200.49M derived: sum of 3 quarters · filed 2020-03-02 | -$230.82M 10-K · filed 2020-03-02 | ||||
| 2018-09-30 | -$65.01M 10-K · filed 2020-03-02 | -$128.43M derived: sum of 2 quarters · filed 2020-03-02 | -$158.76M 10-Q · filed 2019-11-06 | -$180.06M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | -$63.42M 10-K · filed 2020-03-02 | -$93.75M 10-Q · filed 2019-08-07 | -$115.05M derived: sum of 3 quarters · filed 2020-03-02 | -$131.16M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$30.33M 10-K · filed 2020-03-02 | -$51.63M derived: sum of 2 quarters · filed 2020-03-02 | -$67.73M derived: sum of 3 quarters · filed 2020-03-02 | -$87.42M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$21.30M 10-K · filed 2019-03-01 | -$24.95M 10-K · filed 2018-02-28 | -$37.41M derived: sum of 2 quarters · filed 2019-03-01 | -$57.09M derived: sum of 3 quarters · filed 2019-03-01 | -$120.47M 10-K · filed 2020-03-02 | -$108.66M 10-K · filed 2018-02-28 | ||
| 2017-09-30 | -$16.11M 10-K · filed 2019-03-01 | -$12.56M 10-Q · filed 2017-11-07 | -$35.80M derived: sum of 2 quarters · filed 2019-03-01 | -$99.17M 10-Q · filed 2018-11-06 | -$83.71M 10-Q · filed 2017-11-07 | -$133.03M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | -$19.69M 10-K · filed 2019-03-01 | -$11.27M 10-Q · filed 2017-08-09 | -$83.06M 10-Q · filed 2018-08-07 | -$71.15M 10-Q · filed 2017-08-09 | -$116.92M derived: sum of 3 quarters · filed 2019-03-01 | -$136.82M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | -$63.38M 10-K · filed 2019-03-01 | -$59.87M 10-K · filed 2018-02-28 | -$97.23M derived: sum of 2 quarters · filed 2019-03-01 | -$117.13M derived: sum of 3 quarters · filed 2019-03-01 | -$130.84M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | -$33.85M 8-K · filed 2018-09-18 | -$53.76M derived: sum of 2 quarters · filed 2018-09-18 | -$67.46M derived: sum of 3 quarters · filed 2018-09-18 | -$83.51M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | -$19.90M 8-K · filed 2018-09-18 | -$33.61M derived: sum of 2 quarters · filed 2018-09-18 | -$49.65M 10-Q · filed 2017-11-07 | |||||
| 2016-06-30 | -$13.71M 8-K · filed 2018-09-18 | -$29.75M 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | -$16.05M 8-K · filed 2018-09-18 | |||||||
| 2015-12-31 | -$61.44M 8-K · filed 2018-09-18 |